Underwriters Exercise Full Overallotment in Alnylam (ALNY) Offering

January 16, 2013 5:00 PM EST Send to a Friend
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) announced that the underwriters of its previously announced public offering of common stock have exercised their option to purchase an additional 1,200,000 shares at the public offering price of $20.13 per share. As a result, the company will issue a total of 9,200,000 shares in the offering and will receive aggregate net proceeds, after underwriting discounts and commissions and other estimated offering expenses, of approximately $173.8 million. The offering is expected to close on or about January 22, 2013, subject to the satisfaction of customary closing conditions.

J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers and representatives of the underwriters for the offering. Deutsche Bank Securities Inc., Piper Jaffray & Co., Leerink Swann LLC, Needham & Company, LLC and JMP Securities LLC are acting as co-managers for the offering.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Equity Offerings

Related Entities

Piper Jaffray, Deutsche Bank, JPMorgan, Morgan Stanley, Needham & Company, JMP Securities

Add Your Comment